TrialPediatric blood & cancer2017

A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's Oncology Group.

Adam J Esbenshade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.